相关实验视频

Updated: May 4, 2026

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining

Published on: December 23, 2016

在选择PI3K驱动减弱nef变异后,SIV特定的中和抗体诱导

Hiroyuki Yamamoto^1,2,3, Tetsuro Matano^1,3,4

¹AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

|March 3, 2025

概括

研究人员在SIV nef基因中发现了一种特定的突变,可以诱导中和抗体 (NAbs). 这一发现为开发针对HIV等难以中和的病毒的疫苗提供了潜在的战略.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
分子生物学分子生物学

背景情况:

艾滋病毒和SIV感染会损害中和抗体 (NAb) 反应.
驱动NAb诱导的分子特征在很大程度上是未知的.

研究的目的:

为了确定在感染SIV的中诱导NAb的分子特征.
了解影响NAB发展的病毒与宿主相互作用.

主要方法:

对感染SIV的子进行NAB诱导的查.
对病毒突变的分析,特别是在nef基因中.
在体内成像细胞测量以研究B细胞相互作用.

主要成果:

在70只中,有9只出现了SIV特异性的NAbs.
其中七只NAb诱导动物在NAb诱导前在病毒内夫基因中具有特定的CD8+T细胞逃生突变 (Nef-G63E).
这种突变减少了异常的PI3K/mTORC2信号传递,这通常会限制B细胞成熟.
观察到两极化,接触依赖的Nef转移到相关的B细胞的证据.

结论:

一个特定的NEF突变通过调节PI3K/mTORC2信号来促进NAb的诱导.
这种机制与人类PI3K功能增益疾病相反.
准PI3K/mTORC2轴可能会增强NAb诱导,对抗HIV和SIV等具有挑战性的病毒.

关键词:

艾滋病病毒艾滋病病毒艾滋病病毒尼弗尼夫 (Nef Nef Nef) 是指一个有价值的资产.在PI3K中,PI3K是指PI3K.这就是SIV SIV.免疫学免疫学免疫学免疫信号传递是一种免疫信号传递.传染病是一种传染性疾病.这是一种炎症炎症炎症炎症.微生物学的微生物.中和抗体的抗体中和.rhesus 子子子子病毒病毒病毒病毒.

更多相关视频

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.